Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?4.8mm RC, SLActive? 8mm, TiZr, NTP: medical device reports filed with FDA

20,245 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

20,245
device reports naming the brand
0.1% of all MAUDE reports · about 2,929 a year
4,510
reports, 12 months to August 2026
4,024 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 20,245 reports that name the brand "BLT ?4.8mm RC, SLActive? 8mm, TiZr, NTP" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

4,510 reports arrived in the 12 months to August 2026, up 12% from 4,024 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (71.5%), loss of osseointegration (22.7%) and difficult to insert (1%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0476951Sep 2021: 141Oct 2021: 200Nov 2021: 151Dec 2021: 1442022Jan 2022: 239Feb 2022: 137Mar 2022: 163Apr 2022: 182May 2022: 205Jun 2022: 224Jul 2022: 174Aug 2022: 179Sep 2022: 213Oct 2022: 243Nov 2022: 252Dec 2022: 2312023Jan 2023: 170Feb 2023: 239Mar 2023: 213Apr 2023: 226May 2023: 264Jun 2023: 278Jul 2023: 297Aug 2023: 255Sep 2023: 338Oct 2023: 293Nov 2023: 324Dec 2023: 2932024Jan 2024: 304Feb 2024: 282Mar 2024: 282Apr 2024: 403May 2024: 329Jun 2024: 324Jul 2024: 325Aug 2024: 277Sep 2024: 362Oct 2024: 284Nov 2024: 313Dec 2024: 3572025Jan 2025: 262Feb 2025: 298Mar 2025: 291Apr 2025: 172May 2025: 0Jun 2025: 951Jul 2025: 315Aug 2025: 419Sep 2025: 466Oct 2025: 430Nov 2025: 347Dec 2025: 4152026Jan 2026: 350Feb 2026: 355Mar 2026: 319Apr 2026: 295May 2026: 370Jun 2026: 382Jul 2026: 384Aug 2026: 397

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02,1834,3662019: 81320192020: 1,09520202021: 1,64520212022: 2,44220222023: 3,19020232024: 3,84220242025: 4,36620252026: 2,8522026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%20,245
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report77.6%15,708
Voluntary report0%0
User facility report0%0
Distributor report22.4%4,537
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate14,46871.5%62.8%
Loss of osseointegration4,59322.7%22.4%
Difficult to insertthe device was hard to insert1971%0.4%
Separation failure280.1%0.1%
Fracturea broken bone240.1%1.6%
Unstable70%0%
Difficult to removethe device was hard to remove60%0%
Unintended movement30%0%
Defective devicethe device was defective20%0%
Output problem10%0%
Positioning problem10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis6,90434.1%
Painpain, site not specified3,75518.5%
Inflammationinflammation1,3996.9%
Tissue damage1,2306.1%
Swelling/ edema8304.1%
Hemorrhage/blood loss/bleeding7163.5%
Hyperresponsive to stimuli5602.8%
Abscessa collection of pus4162.1%
Fistula3051.5%
Hypersensitivity/allergic reaction2151.1%
Sinus perforation1550.8%
Numbnessnumbness820.4%
Failure of implant630.3%
Swellingswelling540.3%
Increased sensitivity420.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?4.8mm RC, SLActive? 8mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports20,2453,924,24126,136,888
Share of that pool—0.5%0.1%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer77.6%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?4.8mm RC, SLActive? 8mm, TiZr, NTP reports

How many FDA reports name BLT ?4.8mm RC, SLActive? 8mm, TiZr, NTP?

20,245 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 4,510 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (71.5%), loss of osseointegration (22.7%), difficult to insert (1%), separation failure (0.1%) and fracture (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (77.6%) and distributor reports (22.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?4.8mm RC, SLActive? 8mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.